ELEVANCE HEALTH, INC. (ELV) FY2025 Q3 P&L / Income Statement

ELEVANCE HEALTH, INC. (ELV) FY2025 Q3 P&L / Income Statement

Income statement for 2025-07-01 through 2025-09-30. View: Product and service (4 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

50,711,000,000 US dollars

Total expenses

49,305,000,000 US dollars

Operating profit (calculated)

1,406,000,000 US dollars

Other income (expense), net (calculated)

0 US dollars

Income before income tax expense

1,406,000,000 US dollars

Income tax expense

219,000,000 US dollars

Net income

1,187,000,000 US dollars

Total operating revenue

50,087,000,000 US dollars

Net investment income

625,000,000 US dollars

Gain (loss) on sale of business

0 US dollars

Benefit expense

38,140,000,000 US dollars

Cost of products sold

5,380,000,000 US dollars

Operating expense

5,272,000,000 US dollars

Amortization of other intangible assets

162,000,000 US dollars

Interest expense

351,000,000 US dollars

Revenue before reconciliation (calculated)

50,712,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Net losses on financial instruments

negative 1,000,000 US dollars. Reported reconciliation to consolidated revenue.

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
• Of which attributable to ELEVANCE HEALTH, INC.: $1.19 B; to noncontrolling interests: −$2.00 M.